Compliance Rate

Compliance Rate 50.0%
Compliant submissions 1
Incompliant submissions 1
Total trials 2

My Organizations' Clinical Trials

Showing 3400 of 3499 entries
View as:

Continuous Infusion of rhIL-15 for Adults With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01572493 Org: User:
Start: 04/04/12 End: 07/02/19 Due: 07/02/20

Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00002925 Org: User:
Start: 02/28/97 End: 06/30/10 Due: 06/30/11

Oblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00060112 Org: User:
Start: 03/31/03 End: - Due: -

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers

Phase: N/A Priority: Normal
NCT ID: NCT01585428 Org: User:
Start: 04/13/12 End: 08/01/16 Due: 08/01/17

Perillyl Alcohol in Treating Patients With Refractory Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002862 Org: User:
Start: 10/31/96 End: - Due: -

Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps

Phase: N/A Priority: Normal
NCT ID: NCT00005094 Org: User:
Start: 03/31/00 End: - Due: -

Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02417701 Org: User:
Start: 10/06/16 End: 12/28/20 Due: 12/28/21

Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00019136 Org: User:
Start: 02/28/97 End: - Due: -

A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00924209 Org: User:
Start: 03/31/09 End: 09/30/11 Due: 09/30/12

Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye

Phase: N/A Priority: Normal
NCT ID: NCT00020475 Org: User:
Start: 02/28/01 End: 03/31/07 Due: 03/31/08

Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00005970 Org: User:
Start: 05/19/00 End: 01/27/10 Due: 01/27/11

Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00982592 Org: User:
Start: 09/30/09 End: 10/31/14 Due: 10/31/15

Pomalidomide After Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02029950 Org: User:
Start: 12/16/13 End: 05/13/20 Due: 05/13/21

Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01026792 Org: User:
Start: 12/31/09 End: 11/30/12 Due: 11/30/13

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00961220 Org: User:
Start: 02/01/10 End: 04/08/14 Due: 04/08/15

Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02133183 Org: User:
Start: 07/02/14 End: 10/31/23 Due: 10/31/24

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

Phase: N/A Priority: Normal
NCT ID: NCT05554419 Org: User:
Start: 08/29/25 End: 08/31/26 Due: 08/31/27

Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

Phase: N/A Priority: Normal
NCT ID: NCT06246357 Org: User:
Start: 09/23/24 End: 04/01/28 Due: 04/01/29

Depsipeptide/Flavopiridol Infusion for Cancers of the Lungs, Esophagus, Pleura, Thymus or Mediastinum

Phase: N/A Priority: Normal
NCT ID: NCT00094978 Org: User:
Start: 10/25/04 End: 05/20/13 Due: 05/20/14

UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00045500 Org: User:
Start: 06/30/02 End: - Due: -

Mitogen Activated Protein Kinase Kinase (MEK1/2) Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in People With Neurofibromatosis Type 1 (NF1) Mutated Gastrointestinal Stromal Tumors (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT03109301 Org: User:
Start: 04/07/17 End: 03/27/19 Due: 03/27/20

A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT00001382 Org: User:
Start: 03/31/94 End: 03/31/00 Due: 03/31/01

Study of Scaling Disorders and Other Inherited Skin Diseases

Phase: N/A Priority: Normal
NCT ID: NCT00001292 Org: User:
Start: 02/29/92 End: 04/30/01 Due: 04/30/02

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00019448 Org: User:
Start: 09/30/98 End: 03/31/07 Due: 03/31/08

Collection of Tissue Blocks or Slides From Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02810405 Org: User:
Start: 10/03/11 End: 08/26/24 Due: 08/26/25